Incruse Ellipta (umeclidinium) is an long-acting muscarinic antagonist (LAMA). It's an inhaler used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. Incruse Ellipta (umeclidinium) is inhaled through the mouth once per day. People who use Incruse Ellipta (umeclidinium) typically don't experience too many side effects, but ones reported include common cold symptoms, like sore throat and cough.
Incruse Ellipta (umeclidinium) is a long-acting muscarinic antagonist (LAMA), a type of anticholinergic medication. It works by blocking a chemical called acetylcholine to relax the muscles in your airways.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
How to use Incruse Ellipta (umeclidinium):
Incruse Ellipta (umeclidinium) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Don't use Incruse Ellipta (umeclidinium) if you're experiencing trouble breathing because this medication won't provide immediate relief. Use a rescue inhaler, such as albuterol (Ventolin HFA), if you're having trouble breathing.
If you're using your rescue inhaler more often than usual, let your pulmonologist know because this could be a sign that your condition is getting worse. Don't use more doses Incruse Ellipta (umeclidinium) than recommended because this won't improve your breathing. Rather, this can raise your risk for serious side effects, such as heart problems, tremors, and dizziness.
Inhaled medications, including Incruse Ellipta (umeclidinium), can sometimes cause a muscle spasm in your lungs. This can lead to difficulty breathing, wheezing, cough, and chest discomfort. If you have a hard time breathing after inhaling Incruse Ellipta (umeclidinium), use your rescue inhaler and get medical attention right away.
Severe allergic reactions to Incruse Ellipta (umeclidinium) are possible, including life-threatening reactions like facial swelling, shock, and anaphylaxis (closing of the throat). Get medical attention right away if you notice hives, rash, red skin, swelling of the lips or tongue, or difficulty breathing after using Incruse Ellipta (umeclidinium).
Although rare, Incruse Ellipta (umeclidinium) can raise the pressure in your eyes and worsen symptoms of glaucoma. Talk to your optometrist before using Incruse Ellipta (umeclidinium) if you have glaucoma because they might ask you to come in more often for eye exams. Also speak with them if you notice any changes to your vision while using the medication.
Incruse Ellipta (umeclidinium) should be used cautiously by people who have prostate problems or urinary retention, because it can worsen this condition and lead to difficulty urinating. Contact your prescriber if you notice difficulty urinating while using this medication.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 30 blisters of 62.5mcg | 1 inhaler | $348.89 | $348.89 |
Each inhalation of Incruse Ellipta delivers 62.5 mcg of umeclidinium.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Incruse Ellipta (umeclidinium) will not be safe for you to take.
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.Health conditions
Medications & treatment
Access & affordability
Resources
No, Incruse Ellipta isn't a steroid; it's a long-acting muscarinic antagonist (LAMA) that's a bronchodilator. Both inhaled corticosteroids and LAMAs can be used to help with COPD, but they work in different ways. Inhale corticosteroids help you breathe better by lowering inflammation in the airways, whereas LAMAs do so by relaxing the muscles in your airways. Your pulmonologist might prescribe an inhaled steroid for you to use in addition to Incruse Ellipta to help treat COPD.
No, Incruse Ellipta doesn't typically make you tired. Incruse Ellipta can cause certain side effects, such as upper respiratory tract infections and muscle aches, that might make you feel more tired. But tiredness can also be a symptom of worsening COPD. Let your primary care provider know if you're feeling tired. They'll help try to figure out a cause.
When you first start Incruse Ellipta, you might feel improvements in your breathing within a day after a dose. If you don't notice improvements to your breathing after using Incruse Ellipta, your pulmonologist might make changes to your COPD treatment.
Yes, Incruse Ellipta and Breo Ellipta (fluticasone / vilanterol) can be used together if prescribed by your healthcare team. Incruse Ellipta is a long-acting muscarinic antagonist (LAMA), and Breo Ellipta (fluticasone / vilanterol) is an inhaled corticosteroid (ICS) and long acting beta-agonist (LABA). Triple therapy with a LAMA, ICS, and LABA is recommended for certain people who still have severe COPD symptoms even though they're taking Incruse Ellipta. If you need triple therapy, the same manufacturer who makes Incruse Ellipta and Breo Ellipta also makes Trelegy Ellipta, which contains an ICS (fluticasone), LAMA (umeclidinium), and LABA (vilanterol).
Incruse Ellipta isn't FDA-approved for asthma. But other types of long-acting muscarinic antagonists are approved to help with asthma. Talk with your healthcare team if you have more questions about treatment for asthma.
No, hair loss wasn't a side effect reported by people using Incruse Ellipta in clinical studies. If you notice hair loss while you're taking Incruse Ellipta, contact your primary care provider so they can help you figure out possible causes.
No, Incruse Ellipta isn't known to increase (raise) blood pressure. So this medication might be an option for people who have high blood pressure. Talk with your healthcare team if you have more questions about Incruse Ellipta and blood pressure.
Each Incruse Ellipta inhaler has 30 doses, which lasts a month. There's a dose counter on the front face of the Incruse Ellipta inhaler. It should say "30" for a new inhaler. Use this counter to keep track of when you need to get a refill.